{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T06:16:09Z","timestamp":1783577769585,"version":"3.55.0"},"reference-count":36,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T00:00:00Z","timestamp":1783555200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurol."],"abstract":"<jats:p>\n                    Myasthenia gravis (MG) is an autoimmune disease driven by autoantibodies targeting the neuromuscular junction, leading to muscle weakness. Although emerging evidence implicates circular RNAs (circRNAs) in MG, their specific regulatory mechanisms remain largely unknown. In particular, the role of circNUP214 in MG has not been characterized. CircNUP214 expression in PBMCs and CD4\n                    <jats:sup>+<\/jats:sup>\n                    T cells from MG patients and healthy controls was determined by qRT-PCR. Its circular structure and cytoplasmic localization were verified. Furthermore, the interaction between circNUP214 and miR-31 was confirmed, and the regulatory effect of circNUP214 on CD4\n                    <jats:sup>+<\/jats:sup>\n                    T cell proliferation was evaluated. In 31 pure AChR antibody-positive MG patients, circNUP214 expression was significantly elevated in PBMCs compared with healthy controls (HC). Elevated circNUP214 expression was also observed in CD4\n                    <jats:sup>+<\/jats:sup>\n                    T cells. Functionally, circNUP214 promoted CD4\n                    <jats:sup>+<\/jats:sup>\n                    T cell proliferation, while its knockdown suppressed this process. Mechanistically, circNUP214 directly bound miR-31 and upregulated NFAT5 via sponging miR-31. Rescue experiments in Jurkat cells further validated the circNUP214\/miR-31\/NFAT5 ceRNA regulatory axis. In conclusion, circNUP214 is highly expressed in PBMCs from 31 pure AChR antibody positive MG patients and is also elevated in CD4\n                    <jats:sup>+<\/jats:sup>\n                    T cells. It upregulates NFAT5 expression by sponging miR-31 to promote proliferation. These findings suggest that the circNUP214\/miR-31\/NFAT5 axis may contribute to aberrant CD4\n                    <jats:sup>+<\/jats:sup>\n                    T cell proliferation in MG.\n                  <\/jats:p>","DOI":"10.3389\/fneur.2026.1807844","type":"journal-article","created":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T05:36:09Z","timestamp":1783575369000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Circular RNA circNUP214 serves as a microRNA-31 sponge to promote the progression of myasthenia gravis through NFAT5"],"prefix":"10.3389","volume":"17","author":[{"given":"Fanfan","family":"Xu","sequence":"first","affiliation":[{"name":"Department of Neurology, The Second Affiliated Hospital of Harbin Medical University","place":["Harbin, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaotong","family":"Kong","sequence":"additional","affiliation":[{"name":"Department of Neurology, The Second Affiliated Hospital of Harbin Medical University","place":["Harbin, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shanshan","family":"Peng","sequence":"additional","affiliation":[{"name":"Department of Neurology, The Second Affiliated Hospital of Harbin Medical University","place":["Harbin, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lifang","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Neurology, The Second Affiliated Hospital of Harbin Medical University","place":["Harbin, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenqi","family":"Tian","sequence":"additional","affiliation":[{"name":"Department of Neurology, The Second Affiliated Hospital of Harbin Medical University","place":["Harbin, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanlu","family":"Cai","sequence":"additional","affiliation":[{"name":"Department of Neurology, The Second Affiliated Hospital of Harbin Medical University","place":["Harbin, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yichen","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Neurology, The Second Affiliated Hospital of Harbin Medical University","place":["Harbin, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Neurology, The Second Affiliated Hospital of Harbin Medical University","place":["Harbin, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingyan","family":"Niu","sequence":"additional","affiliation":[{"name":"Department of Neurology, The Second Affiliated Hospital of Harbin Medical University","place":["Harbin, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nan","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Neurology, The Second Affiliated Hospital of Harbin Medical University","place":["Harbin, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huixue","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Neurology, The Second Affiliated Hospital of Harbin Medical University","place":["Harbin, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lihua","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Neurology, The Second Affiliated Hospital of Harbin Medical University","place":["Harbin, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,7,9]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"2570","DOI":"10.1056\/NEJMra1602678","article-title":"Myasthenia gravis","volume":"375","author":"Gilhus","year":"2016","journal-title":"N Engl J Med"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1016\/s1474-4422(15)00145-3","article-title":"Myasthenia gravis: subgroup classification and therapeutic strategies","volume":"14","author":"Gilhus","year":"2015","journal-title":"Lancet Neurol"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1038\/s41572-019-0079-y","article-title":"Myasthenia gravis","volume":"5","author":"Gilhus","year":"2019","journal-title":"Nat Rev Dis Primers"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1146\/annurev-immunol-041015-055605","article-title":"Follicular helper T cells","volume":"34","author":"Vinuesa","year":"2016","journal-title":"Annu Rev Immunol"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.clim.2017.03.003","article-title":"CD4(+) FoxP3(+) T regulatory cell subsets in myasthenia gravis patients","volume":"179","author":"Kohler","year":"2017","journal-title":"Clinic Immunol"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"2016","DOI":"10.1016\/j.cell.2022.04.021","article-title":"Circular RNAs: characterization, cellular roles, and applications","volume":"185","author":"Liu","year":"2022","journal-title":"Cell"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1186\/s12943-020-01286-3","article-title":"Circular RNA: metabolism, functions and interactions with proteins","volume":"19","author":"Zhou","year":"2020","journal-title":"Mol Cancer"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"576971","DOI":"10.1016\/j.jneuroim.2019.576971","article-title":"Circular RNAs as a novel layer of regulatory mechanism in multiple sclerosis","volume":"334","author":"Zurawska","year":"2019","journal-title":"J Neuroimmunol"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"e70263","DOI":"10.1096\/fj.202401764r","article-title":"The role of circular RNAs in autoimmune diseases: potential diagnostic biomarkers and therapeutic targets","volume":"39","author":"Li","year":"2025","journal-title":"FASEB J"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1177\/0961203320920706","article-title":"Hsa_circ_0012919 regulates expression of MDA5 by miR-125a-3p in CD4+ T cells of systemic lupus erythematous","volume":"29","author":"Zhang","year":"2020","journal-title":"Lupus"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"535","DOI":"10.3389\/fimmu.2019.00535","article-title":"Regulation of inflammatory functions of macrophages and T lymphocytes by NFAT5","volume":"10","author":"Aramburu","year":"2019","journal-title":"Front Immunol"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"270","DOI":"10.3389\/fimmu.2019.00270","article-title":"Role of NFAT5 in the immune system and pathogenesis of autoimmune diseases","volume":"10","author":"Lee","year":"2019","journal-title":"Front Immunol"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1038\/icb.2016.69","article-title":"Context-dependent regulation of Th17-associated genes and IFN\u03b3 expression by the transcription factor NFAT5","volume":"95","author":"Alberdi","year":"2017","journal-title":"Immunol Cell Biol"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"2287","DOI":"10.1002\/cbin.11676","article-title":"Upregulation of circ-FBL promotes myogenic proliferation in myasthenia gravis by regulation of miR-133\/PAX7","volume":"45","author":"Lai","year":"2021","journal-title":"Cell Biol Int"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"108676","DOI":"10.1016\/j.clim.2021.108676","article-title":"Peripheral blood hsa-circRNA5333-4: a novel biomarker for myasthenia gravis","volume":"224","author":"Lv","year":"2021","journal-title":"Clinic Immunol"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1080\/15476286.2015.1128065","article-title":"CircInteractome: a web tool for exploring circular RNAs and their interacting proteins and microRNAs","volume":"13","author":"Dudekula","year":"2016","journal-title":"RNA Biol"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"D92","DOI":"10.1093\/nar\/gkt1248","article-title":"starBase v2.0: decoding miRNA-ceRNA, miRNA-ncRNA and protein-RNA interaction networks from large-scale CLIP-Seq data","volume":"42","author":"Li","year":"2014","journal-title":"Nucleic Acids Res"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"D296","DOI":"10.1093\/nar\/gkx1067","article-title":"MiRTarBase update 2018: a resource for experimentally validated microRNA-target interactions","volume":"46","author":"Chou","year":"2018","journal-title":"Nucleic Acids Res"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"aav1741","DOI":"10.1126\/science.aav1741","article-title":"The biochemical basis of microRNA targeting efficacy","volume":"366","author":"McGeary","year":"2019","journal-title":"Science"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1038\/nmeth.3485","article-title":"MiRWalk2.0: a comprehensive atlas of microRNA-target interactions","volume":"12","author":"Dweep","year":"2015","journal-title":"Nat Methods"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"D149","DOI":"10.1093\/nar\/gkm995","article-title":"The microRNA.org resource: targets and expression","volume":"36","author":"Betel","year":"2008","journal-title":"Nucleic Acids Res"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"e179742","DOI":"10.1172\/JCI179742","article-title":"Myasthenia gravis: the future is here","volume":"134","author":"Kaminski","year":"2024","journal-title":"J Clin Invest"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"2843","DOI":"10.1172\/JCI29894","article-title":"Myasthenia gravis: past, present, and future","volume":"116","author":"Conti-Fine","year":"2006","journal-title":"J Clin Invest"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"148463","DOI":"10.1016\/j.gene.2024.148463","article-title":"Construction of ceRNA network mediated by circRNAs screening from microarray and identification of novel biomarkers for myasthenia gravis","volume":"918","author":"Kong","year":"2024","journal-title":"Gene"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"885896","DOI":"10.3389\/fimmu.2022.885896","article-title":"Circular RNA circNUP214 modulates the T helper 17 cell response in patients with rheumatoid arthritis","volume":"13","author":"Peng","year":"2022","journal-title":"Front Immunol"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"114672","DOI":"10.1016\/j.biopha.2023.114672","article-title":"Mechanisms of circRNA\/lncRNA-miRNA interactions and applications in disease and drug research","volume":"162","author":"Ma","year":"2023","journal-title":"Biomed Pharmacother"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1038\/nature11993","article-title":"Natural RNA circles function as efficient microRNA sponges","volume":"495","author":"Hansen","year":"2013","journal-title":"Nature"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"1597","DOI":"10.1016\/j.bcp.2006.07.002","article-title":"Regulation of the hypertonic stress response and other cellular functions by the Rel-like transcription factor NFAT5","volume":"72","author":"Aramburu","year":"2006","journal-title":"Biochem Pharmacol"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1038\/s41419-023-06132-0","article-title":"LncRNA Neat1 targets NonO and miR-128-3p to promote antigen-specific Th17 cell responses and autoimmune inflammation","volume":"14","author":"Chen","year":"2023","journal-title":"Cell Death Dis"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1038\/s41419-020-2632-8","article-title":"TonEBP in dendritic cells mediates pro-inflammatory maturation and Th1\/Th17 responses","volume":"11","author":"Ye","year":"2020","journal-title":"Cell Death Dis"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"aag1782","DOI":"10.1126\/scitranslmed.aag1782","article-title":"A miRNA181a\/NFAT5 axis links impaired T cell tolerance induction with autoimmune type 1 diabetes","volume":"10","author":"Serr","year":"2018","journal-title":"Sci Transl Med"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"104515","DOI":"10.1016\/j.cellimm.2022.104515","article-title":"NFAT5 contributes to the pathogenesis of experimental autoimmune encephalomyelitis (EAE) and decrease of T regulatory cells in female mice","volume":"375","author":"Packialakshmi","year":"2022","journal-title":"Cell Immunol"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1038\/nature11868","article-title":"Sodium chloride drives autoimmune disease by the induction of pathogenic TH17 cells","volume":"496","author":"Kleinewietfeld","year":"2013","journal-title":"Nature"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"9595718","DOI":"10.1155\/2016\/9595718","article-title":"miR-20b inhibits T cell proliferation and activation via NFAT signaling pathway in thymoma-associated myasthenia gravis","volume":"2016","author":"Xin","year":"2016","journal-title":"Biomed Res Int"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"4286047","DOI":"10.1155\/2020\/4286047","article-title":"The expression pattern and regulatory mechanism of the G0\/G1 switch gene 2 (G0S2) in the pathogenesis and treatment of AChR myasthenia gravis (MG)","volume":"2020","author":"Xu","year":"2020","journal-title":"Mediat Inflamm"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"2164057","DOI":"10.1155\/2022\/2164057","article-title":"miR-31 from mesenchymal stem cell-derived extracellular vesicles alleviates intervertebral disc degeneration by inhibiting NFAT5 and upregulating the Wnt\/\u03b2-catenin pathway","volume":"2022","author":"Wang","year":"2022","journal-title":"Stem Cells Int"}],"container-title":["Frontiers in Neurology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2026.1807844\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T05:36:10Z","timestamp":1783575370000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2026.1807844\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,9]]},"references-count":36,"alternative-id":["10.3389\/fneur.2026.1807844"],"URL":"https:\/\/doi.org\/10.3389\/fneur.2026.1807844","relation":{},"ISSN":["1664-2295"],"issn-type":[{"value":"1664-2295","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,9]]},"article-number":"1807844"}}